Newsroom
Newsroom
Industry News
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Blog Posts
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Industry News
On Thursday, the company announced it has completed its first commercial-scale fermentation run, which resulted in the production of 116,000liters of thebaine, a key ingredient...
Press Releases
Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMS and APIs...
Blog Posts
Antheia’s Chief Operations Officer Zack McGahey offers his perspective on the company’s most recent commercial milestone – a successful full-scale fermentation run of its first...
Industry News
Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take on the synbio industry's renewed focus...
Industry News
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency and variability within agricultural supply chains remains...
Industry News
In this Contract Pharma Q&A, we sat down with Kristin Brooks to discuss how our company uses fermentation to produce complex APIs for essential medicines....
Industry News
Senior Scientist Chunshun Li received accolades for his contribution to a recent University of Hawaii Cancer Center discovery. In support of lead researcher Shugeng Cao,...
Industry News
While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth....
Industry News
Synthetic biology attracted $8.9 billion in venture funding during the first half of 2021, according to synbio stakeholder group SynBioBeta, and launched two successful initial...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer. ...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Zack McGahey as Chief Operating Officer......
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, announced today that it has raised $73M in Series B financing. The oversubscribed round was led...
Press Releases
Today, three leading synthetic biology companies announced the launch of the Synthetic Biology (SynBio) Coalition (www.synbioco.com) to promote investment and support for the American synthetic...
Press Releases
A new paper published today in the journal Nature describes the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, a class of...
Blog Posts
As the newly appointed Senior Vice President of Commercialization, Richard Sherwin is poised to move Antheia into its next phase by building a vibrant commercial...
Blog Posts
Since launching Antheia in 2015, we’ve made tremendous strides toward our mission to transform pharmaceutical supply chains for essential medicines. We’ve strengthened our leadership team...